Shanghai - Delayed Quote CNY

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

94.30
-0.18
(-0.19%)
At close: June 6 at 3:00:04 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Jinhao Du Chairman of the Board & GM -- -- 1954
Mr. Jie Hu Vice Chairman & Deputy GM -- -- 1975
Mr. Lin Wang Financial Director -- -- 1983
Mr. Chen Huang Marketing Manager -- -- 1975
Mr. Feng Xu Deputy GM & Director -- -- 1965
Ms. Huafeng Shan Chief Quality Officer -- -- 1974
Mr. Huibing Luo Chief Chemistry Officer -- -- 1974
Ms. Shuo Li Board Secretary -- -- 1990
Quan Gan Accounting Supervisor -- -- --
Mr. Huayong Zhou Deputy Director of R&D -- -- 1984

Shanghai Allist Pharmaceuticals Co., Ltd.

No. 268 Lingxiaohua Road
Pudong New Area
Shanghai
China
86 21 8042 3292 https://www.allist.com.cn
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
1,417

Description

Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. The company offers pharmaceuticals for the treatment of tumor and cancer diseases. Shanghai Allist Pharmaceuticals Co., Ltd. was founded in 2004 and is headquartered in Shanghai, China.

Corporate Governance

Shanghai Allist Pharmaceuticals Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 23, 2025 at 10:59 AM UTC

Shanghai Allist Pharmaceuticals Co., Ltd. Earnings Date

Recent Events

June 3, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers